FDA Commissioner Marty Makary said today at the Food and Drug Law Institute’s annual conference: “We want to create a framework for vaccine makers that they can use so they have a predictable FDA where they don’t have to worry how is this going to be received.” The FDA is preparing to release a framework in the coming weeks that will share the agency’s thinking on its oversight of vaccines, Makary explained. Companies who make vaccines include Pfizer (PFE), BioNTech (BNTX), and Moderna (MRNA), GSK (GSK), Novavax (NVAX) and Vaxcyte (PCVX).
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Lawmakers investigating allegations on timing of Pfizer COVID vaccine, WSJ says
- Mixed options sentiment in Pfizer (PFE), with shares up $0.33 (+1.48%) near $22.34
- Pfizer’s Hold Rating: Balancing Policy Uncertainties and Long-Term Growth Prospects
- U.S. biotech companies debate relocating trials outside U.S., Reuters reports
- Terns Pharmaceuticals price target lowered to $15 from $26 at BMO Capital